{
    "Trade/Device Name(s)": [
        "AccuSign\u00ae RC\u00b7DOA10 (MET/OPI/COC/THC/PCP/BZO/BAR/MTD/TCA/AMP)",
        "StatusFirst\u00ae DOA10 (MET/OPI/COC/THC/PCP/BZO/BAR/MTD/TCA/AMP)"
    ],
    "Submitter Information": "Princeton BioMeditech Corporation",
    "510(k) Number": "K062575",
    "Predicate Device Reference 510(k) Number(s)": [
        "K983501"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LAG",
        "DJG",
        "DIO",
        "DKE",
        "DKZ",
        "DIS",
        "DJR",
        "LFI",
        "LCM",
        "JXM"
    ],
    "Summary Letter Date": "October 1, 2007",
    "Summary Letter Received Date": "October 2, 2007",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 862.3160"
    ],
    "Regulation Name(s)": [
        "Methamphetamine Test System"
    ],
    "Analyte Class(es)": [
        "toxicology"
    ],
    "Analyte(s)": [
        "D-Methamphetamine",
        "Morphine",
        "Benzoylecgonine",
        "11-nor-\u0394-9-carboxylic acid",
        "Phencyclidine",
        "Oxazepam",
        "Secobarbital",
        "Methadone",
        "Nortriptyline",
        "D-Amphetamine"
    ],
    "Specimen Type(s)": [
        "Human urine"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "DXpress reader"
    ],
    "Method(s)/Technology(ies)": [
        "Immuno-chromatographic assay",
        "Lateral flow"
    ],
    "Methodologies": [
        "Immunoassay"
    ],
    "Submission Type(s)": [
        "Test",
        "Assay",
        "Reader"
    ],
    "Document Summary": "FDA 510(k) summary for AccuSign RC\u00b7DOA10 and StatusFirst DOA10 lateral flow immunoassays for qualitative detection of 10 drugs of abuse in human urine, compatible with visual and DXpress reader result interpretation.",
    "Indications for Use Summary": "Qualitative detection of methamphetamine, opiates, cocaine metabolite, THC metabolite, phencyclidine, benzodiazepines, barbiturates, tricyclic antidepressants, methadone, and amphetamine in human urine to assist in screening of drug of abuse samples.",
    "fda_folder": "Toxicology"
}